secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2022-03-31T23:59:59+00:00
Accession:  0001510964-22-000016
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences reports FY2021 revenue down 18% to $20.0M; loss narrows to $18.4M
-----------------------------------------------------------------------------

- Revenue of $20.0M for FY2021, down 18% from $24.4M in 2020.
- Gross margin declined to 43.0% from 45.1%; cash fell to $1.4M from $4.5M.
- Operating loss improved to $18.4M from $22.6M; adjusted EBITDA negative $10.0M.
- Retail distribution expanded to 8,400+ stores from 7,300 as of Dec 31, 2021.
- Launched new products; GNC distribution agreement; PPP loan forgiveness of $2.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000016/0001510964-22-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000016/cvsi-20220331.htm
  HTML page:      https://secwatch.observer/filing/0001510964-22-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer